Eric R. Braverman

6.5k total citations · 1 hit paper
117 papers, 4.2k citations indexed

About

Eric R. Braverman is a scholar working on Cellular and Molecular Neuroscience, Psychiatry and Mental health and Cognitive Neuroscience. According to data from OpenAlex, Eric R. Braverman has authored 117 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Cellular and Molecular Neuroscience, 45 papers in Psychiatry and Mental health and 26 papers in Cognitive Neuroscience. Recurrent topics in Eric R. Braverman's work include Neurotransmitter Receptor Influence on Behavior (45 papers), Attention Deficit Hyperactivity Disorder (37 papers) and Diet and metabolism studies (13 papers). Eric R. Braverman is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (45 papers), Attention Deficit Hyperactivity Disorder (37 papers) and Diet and metabolism studies (13 papers). Eric R. Braverman collaborates with scholars based in United States, Taiwan and Israel. Eric R. Braverman's co-authors include Kenneth Blum, Thomas J.H. Chen, Nirav R. Shah, David E. Comings, Peter J. Sheridan, Robert C. Wood, Kenneth Blum, Joel F. Lubar, David Miller and Vincent J. Monastra and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biological Psychiatry.

In The Last Decade

Eric R. Braverman

113 papers receiving 4.0k citations

Hit Papers

The Reward Deficiency Syndrome: A Biogenetic Model for th... 2000 2026 2008 2017 2000 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric R. Braverman United States 31 1.5k 1.3k 926 839 680 117 4.2k
Jerzy Samochowiec Poland 36 1.3k 0.8× 1.3k 1.0× 870 0.9× 517 0.6× 640 0.9× 321 5.4k
Homero Vallada Brazil 39 1.2k 0.8× 1.5k 1.1× 920 1.0× 776 0.9× 425 0.6× 158 5.1k
Igor Elman United States 40 1.7k 1.1× 1.4k 1.1× 890 1.0× 1.8k 2.1× 1.2k 1.7× 141 5.7k
Joseph F. Cubells United States 38 1.3k 0.9× 827 0.6× 1.2k 1.3× 689 0.8× 433 0.6× 109 5.4k
Bryon Adinoff United States 42 1.4k 0.9× 731 0.6× 856 0.9× 1.1k 1.3× 376 0.6× 147 5.0k
Tomás Palomo Spain 39 1.5k 1.0× 1.7k 1.3× 614 0.7× 1.2k 1.4× 330 0.5× 157 4.5k
Veronica O’Keane Ireland 49 861 0.6× 2.2k 1.7× 1.5k 1.6× 567 0.7× 446 0.7× 147 6.8k
Mary M. Heitzeg United States 35 882 0.6× 849 0.7× 995 1.1× 1.6k 1.9× 666 1.0× 106 4.4k
Johan Franck Sweden 37 1.6k 1.0× 749 0.6× 441 0.5× 480 0.6× 501 0.7× 133 4.1k
Marc L. Molendijk Netherlands 32 1.1k 0.7× 737 0.6× 1.3k 1.4× 740 0.9× 583 0.9× 51 4.9k

Countries citing papers authored by Eric R. Braverman

Since Specialization
Citations

This map shows the geographic impact of Eric R. Braverman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric R. Braverman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric R. Braverman more than expected).

Fields of papers citing papers by Eric R. Braverman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric R. Braverman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric R. Braverman. The network helps show where Eric R. Braverman may publish in the future.

Co-authorship network of co-authors of Eric R. Braverman

This figure shows the co-authorship network connecting the top 25 collaborators of Eric R. Braverman. A scholar is included among the top collaborators of Eric R. Braverman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric R. Braverman. Eric R. Braverman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blum, Kenneth, Thomas McLaughlin, Mark S. Gold, et al.. (2023). Are We Getting High Cause the Thrill is Gone?. PubMed. 7(1). 5–516. 1 indexed citations
2.
Blum, Kenneth, Paul R. Carney, Panayotis K. Thanos, et al.. (2023). Psychostimulants for Children: Are We Over or Under Dosing?. PubMed. 7(1). 1–4.
3.
Blum, Kenneth, Igor Elman, Abdalla Bowirrat, et al.. (2022). Should Reward Deficiency Syndrome (RDS) Be Considered an Umbrella Disorder for Mental Illness and Associated Genetic and Epigenetic Induced Dysregulation of Brain Reward Circuitry?. Journal of Personalized Medicine. 12(10). 1719–1719. 10 indexed citations
4.
Blum, Kenneth, Thomas McLaughlin, Abdalla Bowirrat, et al.. (2022). Reward Deficiency Syndrome (RDS) Surprisingly Is Evolutionary and Found Everywhere: Is It “Blowin’ in the Wind”?. Journal of Personalized Medicine. 12(2). 321–321. 23 indexed citations
5.
Modestino, Edward J., Kenneth Blum, Debasis Bagchi, et al.. (2022). Theorizing the Role of Dopaminergic Polymorphic Risk Alleles with Intermittent Explosive Disorder (IED), Violent/Aggressive Behavior and Addiction: Justification of Genetic Addiction Risk Severity (GARS) Testing. Journal of Personalized Medicine. 12(12). 1946–1946. 11 indexed citations
6.
Blum, Kenneth, Abdalla Bowirrat, Jag Khalsa, et al.. (2022). Neurogenetic and Epigenetic Aspects of Cannabinoids. Epigenomes. 6(3). 27–27. 8 indexed citations
7.
Braverman, Eric R., Mark S. Gold, Abdalla Bowirrat, et al.. (2022). Proposing a “Brain Health Checkup (BHC)” as a Global Potential “Standard of Care” to Overcome Reward Dysregulation in Primary Care Medicine: Coupling Genetic Risk Testing and Induction of “Dopamine Homeostasis”. International Journal of Environmental Research and Public Health. 19(9). 5480–5480. 7 indexed citations
8.
Madigan, Margaret, Ashim Gupta, Abdalla Bowirrat, et al.. (2022). Precision Behavioral Management (PBM) and Cognitive Control as a Potential Therapeutic and Prophylactic Modality for Reward Deficiency Syndrome (RDS): Is There Enough Evidence?. International Journal of Environmental Research and Public Health. 19(11). 6395–6395. 5 indexed citations
9.
Gupta, Ashim, Abdalla Bowirrat, David Baron, et al.. (2022). Hypothesizing in the Face of the Opioid Crisis Coupling Genetic Addiction Risk Severity (GARS) Testing with Electrotherapeutic Nonopioid Modalities Such as H-Wave Could Attenuate Both Pain and Hedonic Addictive Behaviors. International Journal of Environmental Research and Public Health. 19(1). 552–552. 7 indexed citations
10.
Blum, Kenneth, David Han, Ashim Gupta, et al.. (2022). Statistical Validation of Risk Alleles in Genetic Addiction Risk Severity (GARS) Test: Early Identification of Risk for Alcohol Use Disorder (AUD) in 74,566 Case–Control Subjects. Journal of Personalized Medicine. 12(9). 1385–1385. 16 indexed citations
11.
Blum, Kenneth, David Han, Abdalla Bowirrat, et al.. (2022). Genetic Addiction Risk and Psychological Profiling Analyses for “Preaddiction” Severity Index. Journal of Personalized Medicine. 12(11). 1772–1772. 6 indexed citations
12.
Blum, Kenneth, Mark S. Brodie, Subhash C. Pandey, et al.. (2022). Researching Mitigation of Alcohol Binge Drinking in Polydrug Abuse: KCNK13 and RASGRF2 Gene(s) Risk Polymorphisms Coupled with Genetic Addiction Risk Severity (GARS) Guiding Precision Pro-Dopamine Regulation. Journal of Personalized Medicine. 12(6). 1009–1009. 9 indexed citations
13.
Blum, Kenneth, Abdalla Bowirrat, Eric R. Braverman, et al.. (2021). Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All Addictions. International Journal of Environmental Research and Public Health. 18(21). 11529–11529. 15 indexed citations
14.
Blum, Kenneth, Mark S. Gold, Panayotis K. Thanos, et al.. (2021). Hypothesizing Nutrigenomic-Based Precision Anti-Obesity Treatment and Prophylaxis: Should We Be Targeting Sarcopenia Induced Brain Dysfunction?. International Journal of Environmental Research and Public Health. 18(18). 9774–9774. 10 indexed citations
15.
Modestino, Edward J., David Siwicki, Lisa Lott, et al.. (2019). Hypodopaminergia and “Precision Behavioral Management” (PBM): It is a Generational Family Affair. Current Pharmaceutical Biotechnology. 21(6). 528–541. 40 indexed citations
16.
Blum, Kenneth, David K. Han, Marlene Oscar‐Berman, et al.. (2013). Iatrogenic opioid dependence is endemic and legal: Genetic addiction risk score (GARS) with electrotherapy a paradigm shift in pain treatment programs. Health. 5(11). 16–34. 1 indexed citations
17.
McLaughlin, Thomas, Marlene Oscar‐Berman, Thomas Simpatico, et al.. (2013). Hypothesizing repetitive paraphilia behavior of a medication refractive Tourette's syndrome patient having rapid clinical attenuation with KB220Z-nutrigenomic amino-acid therapy (NAAT). Journal of Behavioral Addictions. 2(2). 117–124. 20 indexed citations
18.
Braverman, Eric R., et al.. (2010). Test of variables of attention (TOVA) as a predictor of early attention complaints, an antecedent to dementia. SHILAP Revista de lepidopterología. 2 indexed citations
19.
Bowirrat, Abdalla, Thomas J.H. Chen, Kenneth Blum, et al.. (2010). Neuro-psychopharmacogenetics and Neurological Antecedents of Posttraumatic Stress Disorder: Unlocking the Mysteries of Resilience and Vulnerability. Current Neuropharmacology. 8(4). 335–358. 45 indexed citations
20.
Blum, Kenneth, et al.. (2008). Attention-Deficit-Hyperactivity Disorder and Reward Deficiency Syndrome. SHILAP Revista de lepidopterología. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026